Skip to content

Ovarian cancer genetic testing is underused and large gene panels lead to uncertain results, particularly for non-white patients, a Stanford Medicine study finds.

Ovarian cancer genetic testing is underused and large gene panels lead to uncertain results, particularly for non-white patients, a Stanford Medicine study finds.

Published on

In the burgeoning field of pharmacogenetics, adhering to expert-developed guidelines is increasingly important, a Stanford Medicine physician emphasizes.

In the burgeoning field of pharmacogenetics, adhering to expert-developed guidelines is increasingly important, a Stanford Medicine physician emphasizes.

Women with breast cancer are increasingly receiving multigene genetic testing rather than just screening for the BRCA mutations, new research suggests.

Women with breast cancer are increasingly receiving multigene genetic testing rather than just screening for the BRCA mutations, new research suggests.

Published on

Stanford’s Cancer Genetics Program helps assess families' hereditary cancer risks and guide patients to make informed choices about prevention and treatment.

Stanford’s Cancer Genetics Program helps assess families' hereditary cancer risks and guide patients to make informed choices about prevention and treatment.